Evidence map›Paper›PMID 31012051›Full record

ArticleDrug safety2019

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.

Subrata Ghosh, Lianne S Gensler, Zijiang Yang, Chris Gasink, Soumya D Chakravarty, Kamyar Farahi, Paraneedharan Ramachandran, Elyssa Ott, Bruce E Strober

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug safety, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Subrata GhoshInstitute of Translational Medicine and NIHR Birmingham Biomedical Research Centre, University of Birmingham, Office 04, Ground Floor, ITM, North Block, Heritage Building, Mindelson Way, Edgbaston, Birmingham, B15 2TH, UK. s.ghosh@bham.ac.uk.
Lianne S GenslerAxial Spondyloarthritis Clinic, University of California San Francisco, 400 Parnassus Ave., Floor B1, San Francisco, CA, 94143, USA.
Zijiang YangJanssen Research & Development, LLC, 1400 McKean Road, Spring House, PA, 19477, USA.
Chris GasinkJanssen Scientific Affairs, LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Soumya D ChakravartyJanssen Scientific Affairs, LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Kamyar FarahiJanssen Scientific Affairs, LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Paraneedharan RamachandranJanssen Research & Development, LLC, 1400 McKean Road, Spring House, PA, 19477, USA.
Elyssa OttJanssen Scientific Affairs, LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Bruce E StroberDepartment of Dermatology, University of Connecticut Health Center, 21 South Road, 2nd Floor, Farmington, CT, 06030, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of this article, the following correction should be noted in Table 5.

Identifiers

PMID31012051
PMCPMC6520476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.